OpenAlex
PricingAboutJobs
Log inGet started
Work

KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer

HTML

Year: 2010
Type: review
Source: The Lancet Oncology
DOI: 10.1016/s1470-2045(10)70209-6
Authors: Wendy De Roock, Veerle De Vriendt, Nicola Normanno, Fortunato Ciardiello, Sabine Tejpar
Institutions: KU Leuven, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", University of Campania "Luigi Vanvitelli"
Language: English

Topic: Colorectal Cancer Treatments and Studies
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: KRAS mutation, BRAF mutation, PIK3CA mutation, PTEN mutation, metastatic colorectal cancer, anti-EGFR therapy, anti-EGFR monoclonal antibody, MEK inhibition, AKT inhibition, combination therapy, targeted therapy, predictive biomarkers, patient selection
SDG: Good health and well-being

Open Access status: closed

Funders: Associazione Italiana per la Ricerca sul Cancro, Vlaamse regering
OpenAlex ID: W2131371081
FWCI: 4.097
Cites: 82
Cited by: 664
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms